Accessibility Menu
 
Durect logo

Durect

(NASDAQ) DRRX

Current PriceN/A
Market CapN/A
Since IPO (2000)-99%
5 Year-88%
1 Year+27%
1 Month+2%

Durect Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$3.15M

Net Income (TTM)

$3.48M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Durect

Industry

Pharmaceuticals

Employees

13

CEO

James E. Brown, DVM

Headquarters

Cupertino, CA 95014-4166, US

DRRX Financials

Key Financial Metrics (TTM)

Gross Margin

92%

Operating Margin

-10%

Net Income Margin

66%

Return on Equity

13%

Return on Capital

-3%

Return on Assets

6%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Short Interest

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$1.95M

Operating Income

$18.91M

EBITDA

$18.83M

Operating Cash Flow

$19.09M

Capital Expenditure

$0.00

Free Cash Flow

$19.09M

Cash & ST Invst.

$11.80M

Total Debt

$2.21M

Durect Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2025YOY CHG

Revenue

$447.00K

-79.4%

Gross Profit

$440.00K

-75.8%

Gross Margin

98.43%

N/A

Market Cap

N/A

N/A

Market Cap/Employee

N/A

N/A

Employees

21

N/A

Net Income

$2.27M

+38.8%

EBITDA

$2.25M

+31.0%

Quarterly Fundamentals

Name
Q2 2025YOY CHG

Net Cash

$4.75M

+1236.8%

Accounts Receivable

$511.00K

-49.5%

Inventory

$291.00K

-88.2%

Long Term Debt

$652.00K

-70.6%

Short Term Debt

$2.20M

-84.1%

Return on Assets

6.47%

N/A

Return on Invested Capital

-2.78%

N/A

Free Cash Flow

$1.76M

+52.0%

Operating Cash Flow

$1.76M

+52.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
VLNSThe Valens Company Inc.
$0.76+0.00%
SHOTSafety Shot, Inc.
$0.39-7.51%
ZYNEZynerba Pharmaceuticals, Inc.
$1.30+2.36%
LIENChicago Atlantic BDC, Inc.
$9.54-0.26%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$10.91-0.04%
FCUVFocus Universal
$6.55+0.96%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.38+0.01%
SQQQProShares Trust - ProShares UltraPro Short Qqq
$76.72-0.01%

Questions About DRRX

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.